{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:26:17Z","timestamp":1767666377576},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,25]],"date-time":"2014-11-25T00:00:00Z","timestamp":1416873600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12876-014-0199-5","type":"journal-article","created":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T14:01:52Z","timestamp":1416837712000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Different therapeutic approaches on quality of life in patients with inflammatory bowel disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Junjie","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minyue","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihua","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,25]]},"reference":[{"key":"199_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","volume":"28","author":"A Kaser","year":"2010","unstructured":"Kaser A, Zeissig S, Blumberg RS: Inflammatory bowel disease. Annu Rev Immunol. 2010, 28: 573-621. 10.1146\/annurev-immunol-030409-101225.","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"199_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1023\/A:1020841601110","volume":"11","author":"F Casellas","year":"2002","unstructured":"Casellas F, Lopez-Vivancos J, Casado A, Malagelada JR: Factors affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res. 2002, 11 (8): 775-781. 10.1023\/A:1020841601110.","journal-title":"Qual Life Res"},{"issue":"12","key":"199_CR3","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.cgh.2006.09.027","volume":"4","author":"LA Graff","year":"2006","unstructured":"Graff LA, Walker JR, Lix L, Clara I, Rawsthorne P, Rogala L, Miller N, Jakul L, McPhail C, Ediger J, Bernstein CN: The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol. 2006, 4 (12): 1491-1501. 10.1016\/j.cgh.2006.09.027.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"199_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jpsychores.2007.10.007","volume":"64","author":"K Larsson","year":"2008","unstructured":"Larsson K, Loof L, Ronnblom A, Nordin K: Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activity. J Psychosom Res. 2008, 64 (2): 139-148. 10.1016\/j.jpsychores.2007.10.007.","journal-title":"J Psychosom Res"},{"issue":"3","key":"199_CR5","first-page":"173","volume":"8","author":"AH Faust","year":"2012","unstructured":"Faust AH, Halpern LF, Danoff-Burg S, Cross RK: Psychosocial factors contributing to inflammatory bowel disease activity and health-related quality of life. Gastroenterol Hepatol. 2012, 8 (3): 173-181.","journal-title":"Gastroenterol Hepatol"},{"issue":"11","key":"199_CR6","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/ibd.20205","volume":"13","author":"F Casellas","year":"2007","unstructured":"Casellas F, Rodrigo L, Nino P, Pantiga C, Riestra S, Malagelada JR: Sustained improvement of health-related quality of life in Crohn's disease patients treated with infliximab and azathioprine for 4 years. Inflamm Bowel Dis. 2007, 13 (11): 1395-1400. 10.1002\/ibd.20205.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"199_CR7","first-page":"47","volume":"14","author":"A Tursi","year":"2010","unstructured":"Tursi A, Elisei W, Brandimarte G, Giorgetti G, Penna A, Castrignano V: Safety and effectiveness of infliximab for inflammatory bowel diseases in clinical practice. Eur Rev Med Pharmacol Sci. 2010, 14 (1): 47-55.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9317","key":"199_CR8","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","volume":"359","author":"SB Hanauer","year":"2002","unstructured":"Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P, ACCENT I Study Group: Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002, 359 (9317): 1541-1549. 10.1016\/S0140-6736(02)08512-4.","journal-title":"Lancet"},{"issue":"23","key":"199_CR9","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1056\/NEJMoa050516","volume":"353","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF: Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005, 353 (23): 2462-2476. 10.1056\/NEJMoa050516.","journal-title":"N Engl J Med"},{"issue":"7","key":"199_CR10","first-page":"212","volume":"64","author":"C Koelewijn","year":"2006","unstructured":"Koelewijn C, Schrijvers A, Oldenburg B: Infliximab use in patients with Crohn's disease: quality of life, costs and resource use. Neth J Med. 2006, 64 (7): 212-218.","journal-title":"Neth J Med"},{"issue":"4","key":"199_CR11","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1572-0241.2007.01094.x","volume":"102","author":"BG Feagan","year":"2007","unstructured":"Feagan BG, Reinisch W, Rutgeerts P, Sandborn WJ, Yan S, Eisenberg D, Bala M, Johanns J, Olson A, Hanauer SB: The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients. Am J Gastroenterol. 2007, 102 (4): 794-802. 10.1111\/j.1572-0241.2007.01094.x.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"199_CR12","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1111\/j.1572-0241.2003.07674.x","volume":"98","author":"BG Feagan","year":"2003","unstructured":"Feagan BG, Yan S, Bala M, Bao W, Lichtenstein GR: The effects of infliximab maintenance therapy on health-related quality of life. Am J Gastroenterol. 2003, 98 (10): 2232-2238. 10.1111\/j.1572-0241.2003.07674.x.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"199_CR13","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/0016-5085(89)90905-0","volume":"96","author":"G Guyatt","year":"1989","unstructured":"Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, Tompkins C: A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989, 96 (3): 804-810.","journal-title":"Gastroenterology"},{"issue":"3","key":"199_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/00054725-200405000-00014","volume":"10","author":"AG Pallis","year":"2004","unstructured":"Pallis AG, Mouzas IA, Vlachonikolis IG: The inflammatory bowel disease questionnaire: a review of its national validation studies. Inflamm Bowel Dis. 2004, 10 (3): 261-269. 10.1097\/00054725-200405000-00014.","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"199_CR15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/ibd.20128","volume":"13","author":"WH Ren","year":"2007","unstructured":"Ren WH, Lai M, Chen Y, Irvine EJ, Zhou YX: Validation of the mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2007, 13 (7): 903-910. 10.1002\/ibd.20128.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"199_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1751-2980.2010.00431.x","volume":"11","author":"JJ Zheng","year":"2010","unstructured":"Zheng JJ, Zhu XS, Huangfu Z, Shi XH, Guo ZR: Prevalence and incidence rates of Crohn's disease in mainland China: a meta-analysis of 55 years of research. J Dig Dis. 2010, 11 (3): 161-166. 10.1111\/j.1751-2980.2010.00431.x.","journal-title":"J Dig Dis"},{"issue":"1","key":"199_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ibd.21048","volume":"16","author":"CN Bernstein","year":"2010","unstructured":"Bernstein CN, Fried M, Krabshuis JH, Cohen H, Eliakim R, Fedail S, Gearry R, Goh KL, Hamid S, Khan AG, LeMair AW, Malfertheiner , Ouyang Q, Rey JF, Sood A, Steinwurz F, Thomsen OO, Thomson A, Watermeyer G: World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis. 2010, 16 (1): 112-124. 10.1002\/ibd.21048.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"199_CR18","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/0895-4356(96)00136-9","volume":"49","author":"EJ Irvine","year":"1996","unstructured":"Irvine EJ, Feagan BG, Wong CJ: Does self-administration of a quality of life index for inflammatory bowel disease change the results?. J Clin Epidemiol. 1996, 49 (10): 1177-1185. 10.1016\/0895-4356(96)00136-9.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"199_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. conceptual framework and item selection. Med Care. 1992, 30 (6): 473-483. 10.1097\/00005650-199206000-00002.","journal-title":"Med Care"},{"issue":"2","key":"199_CR20","first-page":"109","volume":"48","author":"X Pan","year":"2014","unstructured":"Pan X, Ding C, Pan Y, Zhang A, Wu B, Huang H, Zhu C, Liu D, Zhu B, Xu G, Shao H, Peng S, Jiang X, Zhao C, Han C, Ji H, Yu S, Zhang X, Zhang L, Zheng Y, Yan H: Distribution of copper and zinc in blood among general population from 8 provinces in China. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 2014, 48 (2): 109-113.","journal-title":"Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]"},{"issue":"4","key":"199_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/jech.57.4.259","volume":"57","author":"L Li","year":"2003","unstructured":"Li L, Wang HM, Shen Y: Chinese SF-36 health survey: translation, cultural adaptation, validation, and normalisation. J Epidemiol Community Health. 2003, 57 (4): 259-263. 10.1136\/jech.57.4.259.","journal-title":"J Epidemiol Community Health"},{"issue":"8167","key":"199_CR22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","volume":"1","author":"RF Harvey","year":"1980","unstructured":"Harvey RF, Bradshaw JM: A simple index of Crohn's-disease activity. Lancet. 1980, 1 (8167): 514-10.1016\/S0140-6736(80)92767-1.","journal-title":"Lancet"},{"issue":"1","key":"199_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/gut.43.1.29","volume":"43","author":"RS Walmsley","year":"1998","unstructured":"Walmsley RS, Ayres RC, Pounder RE, Allan RN: A simple clinical colitis activity index. Gut. 1998, 43 (1): 29-32. 10.1136\/gut.43.1.29.","journal-title":"Gut"},{"issue":"1","key":"199_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF02931249","volume":"4","author":"K Tarumi","year":"1999","unstructured":"Tarumi K, Imanaka Y, Isshiki Y, Morimoto K: Quality of life domains in the healthy public: a trial investigation using attendants for an annual health checkup. Environmental Health Prev Med. 1999, 4 (1): 39-48. 10.1007\/BF02931249.","journal-title":"Environmental Health Prev Med"},{"issue":"22","key":"199_CR25","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1001\/jama.289.22.2983","volume":"289","author":"EW Ely","year":"2003","unstructured":"Ely EW, Truman B, Shintani A, Thomason JW, Wheeler AP, Gordon S, Francis J, Speroff T, Gautam S, Margolin R, Sessler CN, Dittus RS, Bernard GR: Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003, 289 (22): 2983-2991. 10.1001\/jama.289.22.2983.","journal-title":"JAMA"},{"issue":"5","key":"199_CR26","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1046\/j.1365-2036.2003.01489.x","volume":"17","author":"RW Leong","year":"2003","unstructured":"Leong RW, Lee YT, Ching JY, Sung JJ: Quality of life in Chinese patients with inflammatory bowel disease: validation of the Chinese translation of the Inflammatory Bowel Disease Questionnaire. Aliment Pharmacol Ther. 2003, 17 (5): 711-718. 10.1046\/j.1365-2036.2003.01489.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"199_CR27","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1002\/ibd.21285","volume":"16","author":"MJ Romberg-Camps","year":"2010","unstructured":"Romberg-Camps MJ, Bol Y, Dagnelie PC, Hesselink-van de Kruijs MA, Kester AD, Engels LG, van Deursen C, Hameeteman WH, Pierik M, Wolters F, Russel MG, Stockbr-gger RW: Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis. 2010, 16 (12): 2137-2147. 10.1002\/ibd.21285.","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"199_CR28","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/hed.21591","volume":"33","author":"OA Hamid","year":"2011","unstructured":"Hamid OA, El Fiky LM, Medani MM, Abdelhady A, Ali HH: Laryngeal cancer in Egypt: quality of life measurement with different treatment modalities. Head Neck. 2011, 33 (8): 1162-1169. 10.1002\/hed.21591.","journal-title":"Head Neck"},{"issue":"3","key":"199_CR29","first-page":"551","volume":"28","author":"ME Galbraith","year":"2001","unstructured":"Galbraith ME, Ramirez JM, Pedro LW: Quality of life, health outcomes, and identity for patients with prostate cancer in five different treatment groups. Oncol Nurs Forum. 2001, 28 (3): 551-560.","journal-title":"Oncol Nurs Forum"},{"issue":"7","key":"199_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.dld.2010.12.014","volume":"43","author":"R Ciccocioppo","year":"2011","unstructured":"Ciccocioppo R, Klersy C, Russo ML, Valli M, Boccaccio V, Imbesi V, Ardizzone S, Porro GB, Corazza GR: Validation of the Italian translation of the inflammatory bowel disease questionnaire. Dig Liver Dis. 2011, 43 (7): 535-541. 10.1016\/j.dld.2010.12.014.","journal-title":"Dig Liver Dis"},{"issue":"2","key":"199_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0016-5085(94)90585-1","volume":"106","author":"EJ Irvine","year":"1994","unstructured":"Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, Kinnear D, Saibil F, McDonald JW: Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology. 1994, 106 (2): 287-296.","journal-title":"Gastroenterology"},{"key":"199_CR32","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1002\/ibd.20556","volume":"14 Suppl 2","author":"HR Clearfield","year":"2008","unstructured":"Clearfield HR: How does IBD affect quality of life?. Inflamm Bowel Dis. 2008, 14 Suppl 2: S45-S46. 10.1002\/ibd.20556.","journal-title":"Inflamm Bowel Dis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-014-0199-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-014-0199-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-014-0199-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-014-0199-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:35:47Z","timestamp":1630564547000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-014-0199-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,25]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["199"],"URL":"https:\/\/doi.org\/10.1186\/s12876-014-0199-5","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,25]]},"assertion":[{"value":"28 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"199"}}